These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26470764)

  • 21. Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series.
    Winterhalter S; Behrens UD; Salchow D; Joussen AM; Pleyer U
    BMC Ophthalmol; 2017 Dec; 17(1):252. PubMed ID: 29246154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
    Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
    Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
    Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
    Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.
    Elhamaky TR
    Indian J Ophthalmol; 2022 Jul; 70(7):2465-2470. PubMed ID: 35791135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitis.
    Lightman S; Belfort R; Naik RK; Lowder C; Foster CS; Rentz AM; Cui H; Whitcup SM; Kowalski JW; Revicki DA
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4864-70. PubMed ID: 23761087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification.
    Gupta A; Ram J; Gupta A; Gupta V
    Ocul Immunol Inflamm; 2013 Dec; 21(6):462-7. PubMed ID: 23941542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis.
    Bratton ML; He YG; Weakley DR
    J AAPOS; 2014 Apr; 18(2):110-3. PubMed ID: 24698604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.
    Ahn SJ; Kim KE; Woo SJ; Park KH
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):160-4. PubMed ID: 24506098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
    Ozkiris A
    Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation.
    Cao JH; Mulvahill M; Zhang L; Joondeph BC; Dacey MS
    Ophthalmology; 2014 Oct; 121(10):1871-6. PubMed ID: 24907061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
    Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
    Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA; Cerón OM; Foster CS
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
    Malone PE; Herndon LW; Muir KW; Jaffe GJ
    Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
    Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
    Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker.
    Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
    Retina; 2014 Aug; 34(8):1612-6. PubMed ID: 24752008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
    Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Results of Interferon-Alpha Treatment in Behçet Uveitis.
    Eser-Ozturk H; Sullu Y
    Ocul Immunol Inflamm; 2020 Apr; 28(3):498-504. PubMed ID: 31161949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.